期刊文献+

糖基化终产物引起晚期内皮祖细胞功能障碍 被引量:1

Advanced Glycation End Products Impair Function of Endothelial Progenitor Cells
下载PDF
导出
摘要 目的观察与糖尿病患者血清浓度类似的糖基化终产物修饰的牛血清白蛋白对体外培养脐血来源晚期内皮祖细胞功能的影响并探讨可能机制。方法密度梯度离心法分离脐血中单个核细胞,用差速贴壁法分离、培养晚期内皮祖细胞。流式细胞术、免疫细胞化学染色及荧光标记的乙酰化低密度脂蛋白、植物凝集素被用于鉴定培养的细胞。将晚期糖基化修饰的牛血清白蛋白与晚期内皮祖细胞共同培养24h后,利用噻唑蓝法检测细胞的增殖能力,AnnexinV/PI双染法流式细胞术检测细胞凋亡;Boyden小室法检测血管内皮生长因子趋化的细胞迁移;ECMatirx-gel检测形成毛细血管样网状结构的能力。利用逆转录聚合酶链反应、蛋白免疫印迹法测定糖基化终产物受体mRNA和蛋白表达水平。结果脐血单个核细胞在体外培养过程中先后出现两种细胞:第5~7天出现集落样生长细胞,扩增不明显,存在14天左右即消失,这类细胞被称为"早期内皮祖细胞";10~15天时,逐渐出现20~50个细胞组成的细胞簇,1~3天即可形成大于500个细胞簇,细胞呈铺路石样,可传代,大于95%的细胞免疫表型为CD45-/CD146+/CD105+,表达内皮细胞特有的vWF因子,可摄取乙酰化低密度脂蛋白并可与荆豆凝集素1结合,这类细胞被称为"晚期内皮祖细胞"。50~400mg/L晚期糖基化修饰的牛血清白蛋白与晚期内皮祖细胞共培养24h后,与对照组相比,细胞的增殖能力未见明显变化(P>0.05)。当晚期糖基化修饰的牛血清白蛋白浓度大于100mg/L时,与对照组相比,晚期内皮祖细胞的凋亡增加(P<0.05)、血管内皮生长因子趋化的迁移以及在ECMatirx-gel上形成新生血管的能力下降(P<0.05),糖基化终产物受体mRNA和蛋白表达均增加(P<0.05)。结论糖基化终产物通过促进凋亡、抑制迁移及体外形成新生血管的能力引起晚期内皮祖细胞功能障碍,这些影响可能与糖基化终产物上调晚期内皮祖细胞上糖基化终产物受体表达有关。 Aim To investigate effects of advanced glycation end products(AGE)modified albumin(AGE-albumin)on functions of late endothelial progenitor cell(EPC)derived from human umbilical cord blood and its mechanisms.Methods Mononuclear cells from human umbilical cord blood were cultured by using EGM-2-MV(Clonetics).Expression of CD45,CD146,and CD105 were detected by fluorescence-activated cell sorter analysis(FACS),vWF was detected by immunocytochemistry.Uptake of acetylated low density lipoprotein(ac-LDL)and binding to Ulex European Agglatinin(UEA-1)were used for fluorescent labeling of EPC.Late EPC were incubated with different concentrations of AGE-albumin which were similar to the diabetic serum for 24 h.MTT was used for EPC proliferation assay.To measure the apoptosis,Annexin V+/PI-cells were detected by FACS analysis.Boyden chamber assay was used to detect the migration by vascular endothelial growth factor(VEGF).Tube formation on ECMatrix-gel was performed to assess the capacity for vasculogenesis.The mRNA and protein expression of AGE receptor(RAGE)were evaluated by reverse-transcriptase polymerase chain reaction(RT-PCR)and Western blotting,respectively.Results There were two types of cells appeared in the culture system.After 3 to 5 d,attached cells appeared and appeared to be clusters.Their number increased for 2 weeks.Thereafter,they did not replicate in vitro and gradually disappeared.We observed another population of cells with different morphology and growth pattern.These appeared in 10 to 15 d after plating,withsmooth cytoplasmic outline and were firmly attached to the plate and showed cobblestone appearance,named late EPC.More than 95% of late EPC were CD45-/CD146+/CD105+and vWF+,took-up ac-LDLand showed UEA-1 binding affin-ity.AGE-albumin concentration-dependently enhanced apoptosis and depressed migration and tube formation,but did not affect proliferation,of late EPC.High AGE-albumin increased RAGE mRNA and protein expression.Conclusion These results suggest that AGE-albumin make impaired function of late EPC,through up-regulation of RAGE in these cells.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2010年第1期1-6,共6页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金(30170370) 江苏省自然科学基金(BK2004083)资助
关键词 糖基化终产物 内皮祖细胞 糖基化终产物受体 糖尿病 血管新生 Advanced Glycation End Product Endothelial Progenitor Cells Advanced Glycation End Product Receptor Diabetes Angiogenesis
  • 相关文献

参考文献15

  • 1Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products : sparking the development of diabetic vascular injury [ J ]. Circulation, 2006, 114 (6) : 597-605.
  • 2Creager MA, Luscher TF, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part 1 [ J ]. Circulation, 2003, 108 (12) : 1 527-532.
  • 3Xu B, Chibber R, Rugglero D, et al. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products [ J ].FASEB J, 2003, 17 (10): 1 289-291.
  • 4Loomans C J, de Koning E J, Staal FJ, et al. Endothelial progenitor cell dysfunction : a novel concept in the pathogenesis of vascular complications of type 1 diabetes [ J]. Diabetes, 2004, 53 (1) : 195-199.
  • 5Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures [J]. Circulation, 2002, 106 (22) : 2 781-786.
  • 6Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovazculogenesis [ J ]. Arterioscler Thromb Vasc Biol, 2004, 24 (2) : 288-293.
  • 7Duan HX, Cheng LM, Wang J, et al. Angiogenic potential difference between two types of endothelial progenitor cells from human umbilical cord blood [J]. CeUBiohu, 2006, 30 (12): 1018-027.
  • 8Xu B, Chibber R, Ruggiero D, et al. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products [ J ]. FASEB J, 2003, 17 (10): 1 289-291.
  • 9Scheubel R J, Kahrstedt S, Weber H, et al. Depression of progenitor cell function by advanced glycation endproducts (AGEs) : potential relevance for impaired angiogenesis in advanced age and diabetes [ J ]. Exp Gerontol, 2006, 41 (5) : 540-548.
  • 10Sun C, Liang C, Ren Y, et al. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways [ J ]. Basic Res Cardiol, 2009, 104 ( 1 ) : 42-49.

二级参考文献24

共引文献3

同被引文献11

  • 1Sarkar Sukumar,Dey Bijan K,Dutta Anindya.MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Molecular Biology . 2010
  • 2Tao Shen,Shile Huang.The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis[J]. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) . 2012 (6)
  • 3Andrea Caporali,Costanza Emanueli.MicroRNA-503 and the Extended MicroRNA-16 Family in Angiogenesis[J]. Trends in Cardiovascular Medicine . 2011 (6)
  • 4Andrea Caporali,Marco Meloni,Christine V?llenkle,Desiree Bonci,Graciela B. Sala-Newby,Roberta Addis,Gaia Spinetti,Sergio Losa,Rachel Masson,Andrew H. Baker,Reuven Agami,Carlos le Sage,Gianluigi Condorelli,Paolo Madeddu,Fabio Martelli,Costanza Emanueli.Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia[J]. Circulation . 2011 (3)
  • 5A.R.R. Forrest,M. Kanamori-Katayama,Y. Tomaru,T. Lassmann,N. Ninomiya,Y. Takahashi,M.J.L. de Hoon,A. Kubosaki,A. Kaiho,M. Suzuki,J. Yasuda,J. Kawai,Y. Hayashizaki,D.A. Hume,H. Suzuki.P42. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation[J]. Differentiation . 2010
  • 6Jian-Jun Zhao,Juhua Yang,Jianhong Lin,Nan Yao,Yihua Zhu,Jianlong Zheng,Jianhua Xu,Jin Q. Cheng,Jian-Yin Lin,Xu Ma.Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis[J]. Child’s Nervous System . 2009 (1)
  • 7XH Wang,RZ Qian,W Zhang,SF Chen,HM Jin,RM Hu.MicroRNA-320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN-LIKE GROWTH FACTOR-1 IN TYPE 2 DIABETIC RATS. Clinical and Experimental Pharmacology and Physiology . 2009
  • 8Howangyin KY,Silvestre JS.Diabetes mellitus and ischemic diseases:molecular mechanisms of vascular repair dysfunc-tion. Arteriosclerosis and Thrombosis . 2014
  • 9Nakashima Taiji,Jinnin Masatoshi,Etoh Tomomi,Fukushima Satoshi,Masuguchi Shinichi,Maruo Keishi,Inoue Yuji,Ishihara Tsuyoshi,Ihn Hironobu.Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PloS one . 2010
  • 10Ajay Subramanian S,Athey Brian D,Lee Inhan.Unified translation repression mechanism for microRNAs and upstream AUGs. BMC Genetics . 2010

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部